Sg Americas Securities, LLC C4 Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$4.43 - $7.38 $110,488 - $184,064
24,941 New
24,941 $142,000
Q1 2024

May 06, 2024
BUY
$5.3 - $11.0 $118,550 - $246,048
22,368 New
22,368 $183,000
Q3 2023

Oct 13, 2023
SELL
$1.81 - $3.89 $1,609 - $3,458
-889 Reduced 6.94%
11,921 $22,000
Q2 2023

Jul 10, 2023
SELL
$2.75 - $3.77 $41,808 - $57,315
-15,203 Reduced 54.27%
12,810 $35,000
Q1 2023

Apr 28, 2023
SELL
$3.1 - $9.02 $41,949 - $122,058
-13,532 Reduced 32.57%
28,013 $88,000
Q4 2022

Feb 02, 2023
BUY
$5.42 - $10.24 $11,311 - $21,370
2,087 Added 5.29%
41,545 $245,000
Q3 2022

Oct 31, 2022
BUY
$8.03 - $12.77 $62,513 - $99,414
7,785 Added 24.58%
39,458 $346,000
Q2 2022

Jul 29, 2022
BUY
$5.06 - $26.46 $160,265 - $838,067
31,673 New
31,673 $239,000
Q1 2022

Apr 29, 2022
SELL
$19.99 - $33.23 $142,908 - $237,561
-7,149 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$29.39 - $46.86 $134,958 - $215,181
-4,592 Reduced 39.11%
7,149 $230,000
Q3 2021

Nov 01, 2021
BUY
$35.91 - $50.5 $267,565 - $376,275
7,451 Added 173.68%
11,741 $525,000
Q2 2021

Aug 12, 2021
BUY
$30.39 - $42.18 $9,664 - $13,413
318 Added 8.01%
4,290 $162,000
Q1 2021

May 13, 2021
BUY
$31.96 - $46.5 $126,945 - $184,698
3,972 New
3,972 $147,000

Others Institutions Holding CCCC

# of Institutions
130
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $170M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email